aTyr Pharma, Inc.
USD0.57
+0.04 (+7.37%)
CEO
Sanjay S. Shukla
IPO Date
2015-05-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.54
Prev. Close
$0.53
Day Low
$0.53
Day High
$0.57
52W Low
$0.40
52W High
$7.29
Market Cap
$0.06B
Volume
1.43M
| 50,000 |
| $0.95 |
| 13 May 2026 | BENEVICH ERIC | director | A-Award | Acquired | 50,000 | $0.95 |
| 13 May 2026 | Gross Jane A | director | A-Award | Acquired | 50,000 | $0.95 |
| 13 May 2026 | Lucas Svetlana | director | A-Award | Acquired | 50,000 | $0.95 |
| 13 May 2026 | Zaknoen Sara | director | A-Award | Acquired | 50,000 | $0.95 |
| 13 May 2026 | SCHIMMEL PAUL | director | A-Award | Acquired | 50,000 | $0.95 |
| 4 Feb 2026 | Shukla Sanjay | director, officer: President and CEO | S-Sale | Disposed | 3,745 | $0.98 |
| 4 Feb 2026 | Shukla Sanjay | director, officer: President and CEO | M-Exempt | Disposed | 10,375 | $0.00 |
| 4 Feb 2026 | Shukla Sanjay | director, officer: President and CEO | M-Exempt | Acquired | 10,375 | $0.00 |